NCT01489774View on ClinicalTrials.gov

Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

June 30, 2012

Conditions
Digestive System Diseases
Interventions
DRUG

Placebo

single and multiple dose

DRUG

CJ-12406

single and multiple dose

Trial Locations (1)

614-735

Inje University Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY